Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: A longitudinal study

Authors: Mitjà O, Godornes C, Houinei W, Kapa A, Paru R, Abel H, González-Beiras C, Bieb SV, Wangi J, Barry AE, Sanz S, Bassat Q, Lukehart SA
Publication Year: 2018
Journal: The Lancet
Link: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30204-6/fulltext%20

Background: Yaws is a substantial cause of chronic disfiguring ulcers in children in at least 14 countries in the tropics. WHO’s newly adopted strategy for yaws eradication uses a single round of mass azithromycin treatment followed by targeted treatment programmes, and data from pilot studies have shown a short-term significant reduction of yaws. We assessed […]
Read More

Single dose azithromycin for the treatment of Haemophilus ducreyi skin ulcers in Papua New Guinea

BACKGROUND: Haemophilus ducreyi (HD) and Treponema pallidum subspecies pertenue (TP) are major causative agents of cutaneous ulcer (CU) in the tropics. Azithromycin is recommended to treat sexually transmitted HD infections and has good in vitro activity against HD strains from both genital and skin ulcers. We investigated the efficacy of oral single-dose azithromycin on HD-CU. […]
Read More

Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: A longitudinal study

Single dose azithromycin for the treatment of Haemophilus ducreyi skin ulcers in Papua New Guinea

About GHTM

Contacts

Map